Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statin therapy in the elderly.

Moira M B Mungall1, Allan Gaw

  • 1Clinical Trials Unit, Glasgow Royal Infirmary, Glasgow, UK.

Current Opinion in Lipidology
|July 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical research benefits go viral via Twitter.

Nursing times·2015
Same author

Ethics in research: practice and respect.

Nursing times·2014
Same author

Reality and revisionism: new evidence for Andrew C Ivy's claim to authorship of the Nuremberg Code.

Journal of the Royal Society of Medicine·2014
Same author

Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study.

PloS one·2013
Same author

Implementing a centralised pharmacovigilance service in a non-commercial setting in the United Kingdom.

Trials·2013
Same author

Lipid metabolism.

Current opinion in lipidology·2012
Same journal

Editorial introduction.

Current opinion in lipidology·2026
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
See all related articles

Statin therapy is now recommended for at-risk elderly patients. Evidence from recent trials supports its use, addressing previous controversies regarding efficacy and safety in older individuals.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Pharmacology

Background:

  • Large-scale trials established statin efficacy and safety, but primarily in patients under 70.
  • The use of statins in elderly populations (over 70) remained controversial due to limited data.

Purpose of the Study:

  • To evaluate the clinical efficacy and safety of statin therapy in elderly patients.
  • To address the controversy surrounding statin use in individuals aged 70 and above.

Main Methods:

  • Analysis of the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
  • Inclusion of elderly cohorts from the Heart Protection Study (HPS).
  • Review of elderly subgroups from other major statin trials.

Main Results:

Related Experiment Videos

  • The PROSPER trial provided significant insights into statin use in the elderly.
  • Data from HPS and other trials demonstrated benefits in elderly subgroups.
  • Findings necessitate a re-evaluation of systematic exclusion of elderly patients from statin therapy.

Conclusions:

  • The collective evidence strongly supports the use of statins in the at-risk elderly population.
  • Statin therapy is indicated for elderly individuals at risk of cardiovascular events.